Free CE/CME Activities
Browse free continuing education activities across medical specialties
Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis
Available through November 25, 2026
James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS
Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies
Emergency Medicine, Neurology, New Drugs
Available through November 22, 2026
Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP
A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control
Available through November 15, 2026
Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD
Clinical Consultations™: Tailoring Treatment for Cystic Fibrosis (CF) Across Life Stages and Evolving Health Needs
Gastroenterology, Pediatrics, Pulmonology
Available through November 14, 2026
Elizabeth Burgener, MD; Leah A. Cohen, MD; William R. Hunt, MD, FAAP, FACP, FSSCI
Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)
Neurology, Nursing, Pediatrics, Rare Diseases
Available through November 1, 2026
Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA
Identifying and Treating Generalized Myasthenia Gravis in the Modern Era
Available through November 1, 2026
James F. Howard Jr, MD, FAAN
Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches
Available through November 1, 2026
Basil T. Darras, MD
Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy
Available through November 1, 2026
Karissa Gable, MD
Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy
Available through November 1, 2026
Basil Williams, MD; Maura Di Nicola, MD
Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet
Available through November 1, 2026
Anne M. Connolly, MD, FAAN; Amy Moore, PhD












